切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Sphingosine kinases (SphKs) - Stearoyl-CoA 9-desaturase (SCD-1) - Topoisomerases - Neuraminidases (NA)

24件产品中的 1-10

页面
每页
清除全部
  1. (S)-10-Hydroxycamptothecin
    B4745 (S)-10-Hydroxycamptothecin
    中文名: 羟喜树碱
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥23.8 mg/mL
      insoluble in H2O
  2. Ellipticine
    B7382 Ellipticine
    中文名: 玫瑰树碱,椭圆玫瑰树碱
    Target: Topoisomerases
    Summary: DNA拓扑异构酶II抑制剂
      ≥24.6 mg/mL
      insoluble in H2O
  3. A939572
    B3607 A939572
     1 Citation
    Target: Stearoyl-CoA 9-desaturase (SCD-1)
    Summary: 硬脂酰辅酶A去饱和酶1(SCD1)抑制剂
      ≥17.15 mg/mL
      insoluble in H2O
  4. Pirarubicin
    B2295 Pirarubicin
     1 Citation
    中文名: 吡柔比星
    Target: Topoisomerases
    Summary: 拓扑异构酶II抑制剂,蒽环类抗生素
      ≥7.65 mg/mL
      insoluble in H2O
  5. Norfloxacin
    B1801 Norfloxacin
    中文名: 诺氟沙星
    Target: Topoisomerases
    Summary: 拓扑异构酶抑制剂
      insoluble in DMSO
      insoluble in H2O
  6. Oseltamivir phosphate
    B1803 Oseltamivir phosphate
     1 Citation
    中文名: 磷酸奥司他韦
    Target: Neuraminidases (NA)
    Summary: 有效的选择性神经氨酸酶抑制剂
      ≥20.3 mg/mL
      ≥110 mg/mL
  7. Irinotecan HCl Trihydrate
    B2293 Irinotecan HCl Trihydrate
    中文名: 盐酸依立替康三水合物
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥23.1 mg/mL
      ≥2.5 mg/mL
  8. K145
    B1298 K145
    Target: Sphingosine kinases (SphKs)
    Summary: SphK2抑制剂
      Soluble in DMSO
  9. Beta-Lapachone
    B2290 Beta-Lapachone
    中文名: β-拉帕醌
    Target: Topoisomerases
    Summary: 选择性DNA拓扑异构酶I抑制剂
      ≥10.85 mg/mL
      insoluble in H2O
  10. SKI II
    B2226 SKI II
    Target: Sphingosine kinases (SphKs)
    Summary: 鞘氨醇激酶(SK)抑制剂
      ≥15.15 mg/mL
      insoluble in H2O

24件产品中的 1-10

页面
每页